These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28360570)

  • 1. The Relationship of White Matter Hyperintensities with Depressive Symptoms and Daily Living Activities in Early-Stage Alzheimer's Disease Patients.
    Bilgiç B; Bayram A; Hanağasi HA; Tümaç A; Uysal P; Şentürk G; Alpsan H; Lohmann E; Gürvit H; Emre M
    Noro Psikiyatr Ars; 2013 Dec; 50(4):360-363. PubMed ID: 28360570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
    Appel J; Potter E; Bhatia N; Shen Q; Zhao W; Greig MT; Raj A; Barker WW; Potter H; Schofield E; Wu Y; Loewenstein DA; Duara R
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1870-6. PubMed ID: 19643919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Correlation Between White Matter Hyperintensity Burden and Regional Brain Volumetry in Patients With Alzheimer's Disease.
    Cao Z; Mai Y; Fang W; Lei M; Luo Y; Zhao L; Liao W; Yu Q; Xu J; Ruan Y; Xiao S; Mok VCT; Shi L; Liu J;
    Front Hum Neurosci; 2022; 16():760360. PubMed ID: 35774484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ; Dadar M; Collins DL; Tartaglia MC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Visual Magnetic Resonance Rating Scale for Evaluation of Patients with Forgetfulness.
    Yalciner BZ; Kandemir M; Taskale S; Tepe SM; Unay D
    Can J Neurol Sci; 2019 Jan; 46(1):71-78. PubMed ID: 30417801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.
    Barber R; Scheltens P; Gholkar A; Ballard C; McKeith I; Ince P; Perry R; O'Brien J
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):66-72. PubMed ID: 10369824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.
    Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study.
    O'Brien JT; Firbank MJ; Krishnan MS; van Straaten EC; van der Flier WM; Petrovic K; Pantoni L; Simoni M; Erkinjuntti T; Wallin A; Wahlund LO; Inzitari D;
    Am J Geriatr Psychiatry; 2006 Oct; 14(10):834-41. PubMed ID: 17001023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
    Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
    Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors related to prevalence, persistence, and incidence of depressive symptoms in mild cognitive impairment: vascular depression construct.
    Kim S; Woo SY; Kang HS; Lim SW; Choi SH; Myung W; Jeong JH; Lee Y; Hong CH; Kim JH; Na H; Carroll BJ; Kim DK
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):818-26. PubMed ID: 26679895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corpus callosum atrophy, white matter lesions, and frontal executive dysfunction in normal aging and Alzheimer's disease. A community-based study: the Tajiri Project.
    Meguro K; Constans JM; Shimada M; Yamaguchi S; Ishizaki J; Ishii H; Yamadori A; Sekita Y
    Int Psychogeriatr; 2003 Mar; 15(1):9-25. PubMed ID: 12834197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.
    Caroli A; Testa C; Geroldi C; Nobili F; Guerra UP; Bonetti M; Frisoni GB
    J Neurol; 2007 Aug; 254(8):1000-8. PubMed ID: 17375260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-Dependent Cerebral Blood Flow and Leukoaraiosis Couplings in Subcortical Ischemic Vascular Disease and Alzheimer's Disease.
    Tu MC; Chung HW; Hsu YH; Yang JJ; Wu WC
    J Alzheimers Dis; 2022; 86(2):729-739. PubMed ID: 35124651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter hyperintensities in mild cognitive impairment: clinical impact of location and interaction with lacunes and medial temporal atrophy.
    Yoon B; Shim YS; Cheong HK; Hong YJ; Lee KS; Park KH; Ahn KJ; Kim DJ; Kim YD; Choi SH; Yang DW
    J Stroke Cerebrovasc Dis; 2014; 23(5):e365-72. PubMed ID: 24589036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.